US 11312692
Polymorphic compounds and uses thereof
granted A61PA61P27/02
Quick answer
US patent 11312692 (Polymorphic compounds and uses thereof) held by Aldeyra Therapeutics, Inc. expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aldeyra Therapeutics, Inc.
- Grant date
- Tue Apr 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P27/02